This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Wadasadawala T, Vadgaonkar R, Bajpai J. Management of Isolated Locoregional Recurrences in Breast Cancer: A Review of Local and Systemic Modalities. Clin Breast Cancer. 2017 Nov; 17 (7): 493-502.WadasadawalaTVadgaonkarRBajpaiJManagement of Isolated Locoregional Recurrences in Breast Cancer: A Review of Local and Systemic Modalities2017Nov17749350210.1016/j.clbc.2017.03.008Search in Google Scholar
Harms W, Geretschläger A, Cescato C, Buess M, Köberle D, Asadpour B. Current Treatment of Isolated Locoregional Breast Cancer Recurrences. Breast Care 2015; 10: 265–271.HarmsWGeretschlägerACescatoCBuessMKöberleDAsadpourBCurrent Treatment of Isolated Locoregional Breast Cancer Recurrences20151026527110.1159/000439151Search in Google Scholar
Elsayed M, Alhussini M, Basha A and Awad A. T. Analysis of loco-regional and distant recurrences in breast cancer after conservative surgery. World Journal of Surgical Oncology (2016) 14:144ElsayedMAlhussiniMBashaAandAwadA. T.Analysis of loco-regional and distant recurrences in breast cancer after conservative surgery20161414410.1186/s12957-016-0881-xSearch in Google Scholar
Van Tienhoven G, Voogd AC, Peterse JL, et al.: Prognosis after treatment for locoregional recurrence after mastectomy or breast conserving therapy in two randomized trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group. Eur J Cancer 1999,35: 32–38.VanTienhoven GVoogdACPeterseJLet alPrognosis after treatment for locoregional recurrence after mastectomy or breast conserving therapy in two randomized trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group199935323810.1016/S0959-8049(98)00301-3Search in Google Scholar
Karlsson P, Cole BF, Price KN, Gelber RD, Coates AS, Goldhirsch A. Timing of radiotherapy and chemotherapy after breast-conserving surgery for node-positive breast cancer: long-term results from IBCSG Trials VI and VIIInt J Radiat Oncol Biol Phys. 2016 October 1; 96(2): 273–279KarlssonPColeBFPriceKNGelberRDCoatesASGoldhirschA2016October 196227327910.1016/j.ijrobp.2016.06.2448Search in Google Scholar
Liu Y, Zhai X, Li J, Li Z, Ma D and Wang Z. Is there an optimal time to initiate adjuvant chemotherapy to predict benefit of survival in non-small cell lung cancer? Chin J Cancer Res. 2017; 29(3): 263–271LiuYZhaiXLiJLiZMaD and Wang ZIs there an optimal time to initiate adjuvant chemotherapy to predict benefit of survival in non-small cell lung cancer?201729326327110.21147/j.issn.1000-9604.2017.03.12Search in Google Scholar
Chay C, Smith DC. Adjuvant and neoadjuvant therapy in prostate cancer. Semin Oncol. 2001; 28(1): 3-12.ChayCSmithDCAdjuvant and neoadjuvant therapy in prostate cancer200128131210.1016/S0093-7754(01)90041-7Search in Google Scholar
Dąbrowska A M, Słotwiński R. The immune response to surgery and infection. Centr Eur J Immunol 2014; 39 (4): 532-537DąbrowskaA MSłotwińskiRThe immune response to surgery and infection201439453253710.5114/ceji.2014.47741443996826155175Search in Google Scholar
Gupta AA, Pande N, Kheur S, Raj AT. Assessing the potential role of scafold-mediated local chemotherapy in oral cancer. Oral Oncol. 2018. https://doi.org/10.1016/j.oraloncology.2018.03.009GuptaAAPandeNKheurSRajATAssessing the potential role of scafold-mediated local chemotherapy in oral cancer2018https://doi.org/10.1016/j.oraloncology.2018.03.00910.1016/j.oraloncology.2018.03.00929555306Search in Google Scholar
Kretlow JD, Mikos AG. From material to tissue: biomaterial development, scafold fabrication, and tissue engineering. AIChE J. 2008; 54(12): 3048-67.KretlowJDMikosAGFrom material to tissue: biomaterial development, scafold fabrication, and tissue engineering2008541230486710.1002/aic.11610274350719756176Search in Google Scholar
Langer R. Biomaterials in drug delivery and tissue engineering: one laboratory’s experience. Acc Chem Res. 2000; 33: 94–101.LangerRBiomaterials in drug delivery and tissue engineering: one laboratory’s experience2000339410110.1021/ar9800993Search in Google Scholar
Hutmacher DW. Scafolds in tissue engineering bone and cartilage. Biomaterials. 2000; 21: 2529–43.HutmacherDWScafolds in tissue engineering bone and cartilage20002125294310.1016/S0142-9612(00)00121-6Search in Google Scholar
Shea LD, Smiley E, Bonadio J, Mooney DJ. DNA delivery frompolymer matrices for tissue engineering. Nat Biotechnol. 1999; 17: 551–4.SheaLDSmileyEBonadioJMooneyDJDNA delivery frompolymer matrices for tissue engineering199917551410.1038/9853Search in Google Scholar
Hoffman AS. Hydrogels for biomedical applications. Adv Drug Deliv Rev. 2002; 43: 3–12.HoffmanASHydrogels for biomedical applications20024331210.1016/S0169-409X(01)00239-3Search in Google Scholar
Drury JL, Mooney DJ. Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials. 2003; 24: 4337–51.DruryJLMooneyDJHydrogels for tissue engineering: scaffold design variables and applications20032443375110.1016/S0142-9612(03)00340-5Search in Google Scholar
Lyons F, Partap S, O’Brien FJ. Part 1: scaffolds and surfaces. Technol Health Care. 2008; 16: 305–17.LyonsFPartapSO’BrienFJPart 1: scaffolds and surfaces2008163051710.3233/THC-2008-16409Search in Google Scholar
Khang G, Lee SJ, Kim MS, Lee HB. Biomaterials: tissue engineering and scaffold. In Webster J (ed.). Encyclopedia of Medical Devices and Instrumentation, Vol 2; 2006: 366–83.KhangGLeeSJKimMSLeeHBBiomaterials: tissue engineering and scaffoldInWebsterJed2006366–8310.1002/0471732877.emd029Search in Google Scholar
Chung HJ, Park TG. Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering. Adv Drug Deliv Rev. 2007;59:249–59.ChungHJParkTGSurface engineered and drug releasing pre-fabricated scaffolds for tissue engineering2007592495910.1016/j.addr.2007.03.01517482310Search in Google Scholar
Karande ST, Agrawal MC. Functions and requirement of synthetic scaffolds in tissue engineering. In: Laurencin CT, Nair LS (eds.). Nanotechnology and Tissue Engineering: The Scaffolds; 2008:53.KarandeSTAgrawalMCFunctions and requirement of synthetic scaffolds in tissue engineeringInLaurencinCTNairLSedsThe Scaffolds20085310.1201/9781420051834.ch3Search in Google Scholar
Ma PX. Biomimetic materials for tissue engineering. Adv Drug Deliv Rev. 2008; 60:184–98.MaPXBiomimetic materials for tissue engineering2008601849810.1016/j.addr.2007.08.041227103818045729Search in Google Scholar
Drury JL, Mooney DJ. Hydrogels for tissue engineering: scaffold design variablesand applications. Biomaterials. 2003; 24: 4337–51.DruryJLMooneyDJHydrogels for tissue engineering: scaffold design variablesand applications20032443375110.1016/S0142-9612(03)00340-5Search in Google Scholar
Hoffman AS. Hydrogels for biomedical applications. Adv Drug Deliv Rev. 2002; 43: 3–12.HoffmanASHydrogels for biomedical applications20024331210.1016/S0169-409X(01)00239-3Search in Google Scholar
Augst AD, Kong HJ, Mooney DJ. Alginate hydrogels as biomaterials. Macromol Biosci. 2006; 6: 623–33.AugstADKongHJMooneyDJAlginate hydrogels as biomaterials200666233310.1002/mabi.20060006916881042Search in Google Scholar
Huang S, Fu X. Naturally derived materials-based cell and drug delivery systems in skin regeneration. J Control Release. 2010;142:149–59.HuangSFuXNaturally derived materials-based cell and drug delivery systems in skin regeneration20101421495910.1016/j.jconrel.2009.10.01819850093Search in Google Scholar
Park CJ, Clark SG, Lichtensteiger CA, Jamison RD, Johnson AJ. Accelerated wound closure of pressure ulcers in aged mice by chitosan scaffolds with and without bFGF. Acta Biomater. 2009; 5: 1926–36.ParkCJClarkSGLichtensteigerCAJamisonRDJohnsonAJAccelerated wound closure of pressure ulcers in aged mice by chitosan scaffolds with and without bFGF2009519263610.1016/j.actbio.2009.03.00219342320Search in Google Scholar
Clark RAF, Singer AJ. Wound repair: basic biology to tissue engineering. London: Academic Press; 2000.ClarkRAFSingerAJLondonAcademic Press200010.1016/B978-012436630-5/50065-9Search in Google Scholar
Bradley M, Cullum N, Nelson EA, Petticrew M, Sheldon T, Torgerson D. Systematic reviews of wound care management: (2). Dressings and topical agents used in the healing of chronic wounds. Health Technol Assess. 1999; 3: 1–35.BradleyMCullumNNelsonEAPetticrewMSheldonTTorgersonDSystematic reviews of wound care management: (2)1999313510.3310/hta3172Search in Google Scholar
Lee JE, Park JC, Lee HK, Oh SH, Suh H. Laminin modified infection-preventing collagen membrane containing silver sulfadiazine–hyaluronan microparticles. Artif Organs. 2002; 26: 521–8.LeeJEParkJCLeeHKOhSHSuhHLaminin modified infection-preventing collagen membrane containing silver sulfadiazine–hyaluronan microparticles200226521810.1046/j.1525-1594.2002.06890.x12072108Search in Google Scholar
Costa PF. Bone tissue engineering drug delivery. Current Molecular Biology Reports. 2015; 1: 87-93.CostaPFBone tissue engineering drug delivery20151879310.1007/s40610-015-0016-0Search in Google Scholar
Yao Q, Liu Y, Selvaratnam B, Ranjit T. Koodali D, Sun H. Mesoporous Silicate Nanoparticles/3D Nanofibrous Scaffold-mediated Dual-drug Delivery for Bone Tissue Engineering. doi:10.1016/j.jconrel.2018.04.011YaoQLiuYSelvaratnamBRanjitTKoodaliDSunH10.1016/j.jconrel.2018.04.011597206629649529Open DOISearch in Google Scholar
Agila S. Poornima J. Magnetically Controlled Nano-Composite Based 3D Printed Cell Scaffolds As Targeted Drug Delivery Systems For Cancer Therapy. Proceedings of the 15th IEEE International Conference on Nanotechnology July 27-30, 2015, Rome, Italy.AgilaSPoornimaJ2015Rome, Italy10.1109/NANO.2015.7388803Search in Google Scholar
Dai J, Jin J, Yang S and Li G. Doxorubicin-loaded PLA/pearl electrospun nanofibrous scaffold for drug delivery and tumor cells treatment. Mater. Res 2017. Express, at press: https://doi.org/10.1088/2053-1591/aa7479DaiJJinJYangS and Li GDoxorubicin-loaded PLA/pearl electrospun nanofibrous scaffold for drug delivery and tumor cells treatment2017Express, at presshttps://doi.org/10.1088/2053-1591/aa747910.1088/2053-1591/aa7479Search in Google Scholar
Bagó J R., Pegna G J., Okolie O, Mohiti-Asli M, Loboa E G, Hingtgen S D. Electrospun nanofibrous scaffolds increase the efficacy of stem cell-mediated therapy of surgically resected glioblastoma DOI: 10.1016/j.biomaterials.2016.03.008BagóJ RPegnaG J.OkolieOMohiti-AsliMLoboaE GHingtgenS D10.1016/j.biomaterials.2016.03.008Open DOISearch in Google Scholar
Bao H, Zhang Q, Xu H, Yan Z. Effects of nanoparticle size on antitumor activity of 10-hydroxycamptothecin-conjugated gold nanoparticles: in vitro and in vivo studies. International Journal of Nanomedicine 2016:11 929–940.BaoHZhangQXuHYanZEffects of nanoparticle size on antitumor activity of 10-hydroxycamptothecin-conjugated gold nanoparticles: in vitro and in vivo studies201611929–94010.2147/IJN.S96422Search in Google Scholar
Chaudhari AA, Vig K, Baganizi DR, Sahu R, Dixit S, Dennis V et al. Future Prospects for Scaffolding Methods and Biomaterials in Skin Tissue Engineering: A Review. Int. J. Mol. Sci. 2016, 17, 1974; doi:10.3390/ijms17121974.ChaudhariAAVigKBaganiziDRSahuRDixitSDennisVet alFuture Prospects for Scaffolding Methods and Biomaterials in Skin Tissue Engineering: A Review201617197410.3390/ijms17121974Open DOISearch in Google Scholar
Grigore ME. Drug Delivery Systems in Hard Tissue Engineering. SF J Biotechnol Biomed Eng. 2018; 1(1): 1001.GrigoreMEDrug Delivery Systems in Hard Tissue Engineering2018111001Search in Google Scholar
Garg T, Singh O, Arora S & Murthy RSR. Scaffold: A Novel Carrier for Cell and Drug Delivery. Critical Reviews™ in Therapeutic Drug Carrier Systems 2012; 29(1): 1–63.GargTSinghOAroraS&MurthyRSR.Scaffold: A Novel Carrier for Cell and Drug Delivery201229116310.1615/CritRevTherDrugCarrierSyst.v29.i1.10Search in Google Scholar
Jaisinghani A, Gupta A, Raj AT. The potential use of scaffold-mediated local delivery of bone modulators in accelerated orthodontics: A hypotheses. Medical Hypotheses 2018, doi: https://doi.org/10.1016/j mehy. 2018.07.005.JaisinghaniAGuptaARajATThe potential use of scaffold-mediated local delivery of bone modulators in accelerated orthodontics: A hypotheses2018https://doi.org/10.1016/jmehy. 2018.07.00510.1016/j.mehy.2018.07.005Search in Google Scholar
Aliperta, R, Welzel PB, Bergmann R, Freudenberg U, Berndt N, Feldmann A et al. Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy. Sci. Rep. 7, 42855; doi: 10.1038/srep42855(2017).AlipertaRWelzelPBBergmannRFreudenbergUBerndtNFeldmannAet alCryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy74285510.1038/srep42855(2017)Open DOISearch in Google Scholar
Lokteva A, Haberkorna U, Mier W. Multicyclic Peptides as Scaffolds for the Development of Tumor Targeting Agents. Current Medicinal Chemistry, 2016.LoktevaAHaberkornaUMierWMulticyclic Peptides as Scaffolds for the Development of Tumor Targeting Agents201610.2174/092986732466617031612030428302013Search in Google Scholar